The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province …

X Zhen, Y Chen, X Hu, P Dong, S Gu, YY Sheng… - European Journal of …, 2017 - Springer
This retrospective study aims to compare differences in the medical costs between inpatients
infected/colonised with carbapenem-resistant (CRAB) and carbapenem-susceptible (CSAB) …
被引用次数：27 相关文章

The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province …

X Zhen, Y Chen, X Hu, P Dong, S Gu… - … Journal of Clinical …, 2017 - search.proquest.com
This retrospective study aims to compare differences in the medical costs between inpatients
infected/colonised with carbapenem-resistant (CRAB) and carbapenem-susceptible (CSAB) …

The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province …

X Zhen, Y Chen, X Hu, P Dong, S Gu… - … Journal of Clinical …, 2017 - search.ebscohost.com
This retrospective study aims to compare differences in the medical costs between inpatients
infected/colonised with carbapenem-resistant (CRAB) and carbapenem-susceptible (CSAB) …

The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province …

X Zhen, Y Chen, X Hu, P Dong, S Gu… - … journal of clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
This retrospective study aims to compare differences in the medical costs between inpatients
infected/colonised with carbapenem-resistant (CRAB) and carbapenem-susceptible (CSAB) …

The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province …

X Zhen, Y Chen, X Hu, P Dong, S Gu, YY Sheng… - 2017 - cabidigitallibrary.org
This retrospective study aims to compare differences in the medical costs between inpatients
infected/colonised with carbapenem-resistant (CRAB) and carbapenem-susceptible (CSAB) …

The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province …

X Zhen, Y Chen, X Hu, P Dong, S Gu… - European Journal of …, 2017 - europepmc.org
This retrospective study aims to compare differences in the medical costs between inpatients
infected/colonised with carbapenem-resistant (CRAB) and carbapenem-susceptible (CSAB) …